A newly identified SARS-CoV-2 lineage, designated as PJ.2.1, has triggered global public health tracking following its rapid spread across multiple continents. First detected in Ontario, Canada, on May 2, 2026, the lineage has since been logged in the United States, Spain, France, Singapore, Australia, New Zealand, and Israel.
Health tracking networks classify PJ.2.1 as a saltation variant due to an unusually high concentration of mutations in its spike protein compared to its parent lineage. The World Health Organization (WHO) and international surveillance bodies are closely monitoring its growth advantage over other circulating strains.